Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for prevention of nausea and vomiting after pediatric upper GI endoscopy
IRCT20180929041173N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in postoperative nausea and vomiting (PONV) comparing Dexamethasone with Normal saline placebo (2 arms). Primary endpoint: Incidence of nausea/vomiting after endoscopy. Started Nov 2018; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20180929041173N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180929041173N1.